Skip to content Skip to search Skip to footer
WashU Medicine

Dominantly Inherited Alzheimer Network (DIAN)

Menu
  • Join the Registry
    • Individuals & Families
    • Researchers & Health Professionals
  • For Families
    • Genetic Counseling & Testing
    • Family Conferences
    • Video Gallery
    • Family Voices
    • DIAN in Latin America
    • EXR Newsletter
    • Webinars
    • Resources
    • Brain Donation
    • Message from Our Directors
  • Observational Study
    • Obs Study Sites
    • Study Description
    • Participation
    • Procedures
    • Advisory & Steering Committee
    • Funding: DIAN Obs Study
  • Clinical Trials
    • TU Participating Sites
    • Primary Prevention Trial
    • Secondary Prevention Trial
    • Research Updates
    • Funding
    • DIAN-TU History
  • Our Research
    • For Investigators
    • Our Collaborators
    • Research Fellows
    • DIAN Symposium
    • Pharma Consortium
    • Publications
    • Latin America Expansion
  • About us
    • The DIAN Team
    • Committees
    • Contact
  • News & Updates

Author: Ellen

LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE (Links to an external site)

September 28, 2022

Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease (Links to an external site)

June 16, 2022

Could drugs prevent Alzheimer’s? These trials aim to find out (Links to an external site)

March 9, 2022

Blood test for Alzheimer’s highly accurate in large, international study (Links to an external site)

February 23, 2022

First Subject Enrolled in Phase II/III Study of Eisai’s Anti-MTBR Tau Antibody E2814 for Dominantly Inherited Alzheimer’s Disease (DIAD), conducted by DIAN-TU (Links to an external site)

January 19, 2022January 21, 2022

New Alzheimer’s prevention trial in young people (Links to an external site)

December 20, 2021

$11.5 million commitment supports new Alzheimer’s prevention clinical trial (Links to an external site)

December 20, 2021

International Alzheimer’s clinical trial to test two drugs in combination (Links to an external site)

November 8, 2021

Global Incubator Seed Grants awarded (Links to an external site)

September 28, 2021

The Search for a Drug to End Alzheimer’s (Links to an external site)

June 3, 2021

Some antiamyloids remove target plaques from the brain, yet don’t seem to halt cognitive decline. Researchers are working to understand why.

Posts navigation

Previous Page
4 of 13
Next Page

DIAN

Dominantly Inherited Alzheimer Network

WashU Medicine

660 S. Euclid Ave.

Campus Box 8111

St. Louis, MO 63110

 

Contact Us

Links

  • Investigator Resources
  • Current Participating Sites
  • DIAN Research Updates

Make a Difference

Your thoughtful contribution enables us to continue researching possible treatments and ultimately cures for this devastating disease.

DONATE

©2026 Washington University in St. Louis